Ticker
QLGNCompany Name
QUALIGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
---|---|---|---|
6/30/2025 | -95.98% | $ 2.98M | $ 2.86M |
3/31/2025 | -24.92% | $ 5.02M | $ 1.25M |
12/31/2024 | -17.48% | $ 5.58M | $ 975.98K |
9/30/2024 | -45.65% | $ 2.99M | $ 1.36M |
6/30/2024 | -37.39% | $ 2.47M | $ 925K |
3/31/2024 | 4.71% | $ 1.59M | $ -75K |
12/31/2023 | 22.86% | $ 2.41M | $ -550K |
9/30/2023 | -64.7% | $ 3.81M | $ 2.46M |
6/30/2023 | -54.74% | $ 5.31M | $ 2.9M |
3/31/2023 | -56.35% | $ 5.15M | $ 2.9M |
(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield
Debt Paydown Yield for QUALIGEN THERAPEUTICS INC is calculated as follows: (-1 * CF - Debt [ $ 428.29K ]) / Market Cap [ $ 80.48M ]
(=) Debt Paydown Yield [ -0.53% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -11.5% |
max | 11.49% |
average | -0.08% |
median | 0% |
std | 3.82% |